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ABSTRAK 
 
FAKTOR RISIKO DAN HASIL AKIBAT JANGKITAN KUMAN GRAM 
NEGATIF DALAM DARAH YANG RESISTAN CARBAPENEM DI UNIT 
RAWATAN RAPI (ICU), HUSM 
 
Objektif : Jangkitan kuman gram negatif semakin berleluasa dan amat 
membimbangkan. Penyelidikan ini dijalankan bertujuan untuk mengenalpasti faktor 
risiko dan juga hasil akibat jangkitan kuman Gram negatif di dalam darah pesakit-
pesakit ICU, Hospital Universiti Sains Malaysia (HUSM).  
 
Metodologi : Retrospektif, dijalankan secara perbandingan “case-control”. Faktor risiko 
terhadap jangkitan kuman Gram negatif dikenalpasti dengan membandingkan dua 
kumpulan pesakit : kumpulan pertama (control) terdiri daripada kes yang mempunyai 
jangkitan kuman Gram negatif yang sensitive kepada Carbapenem dan kumpulan kedua 
(case) pula terdiri daripada kes yang resistan. Kedua-dua kumpulan ini adalah kes yang 
dirawat di ICU dalam tempoh yang sama dan memenuhi syarat-syarat kriteria yang 
diperlukan. 96 sample tersebut telah dipilih secara rawak dan rekod perubatan kes-kes 
ini dilihat kembali. Data demografik, sejarah penyakit dahulu, penggunaan antibiotik, 
keputusan mikrobiologi dan hasilnya dicatat. 
 
Keputusan : Daripada 96 sampel yang dikaji, sebanyak 48 kes yang resistan telah 
dibandingkan dengan 48 kes yang sensitif terhadap Carbapenem. Antara faktor risiko 
yang dikenalpasti menyebabkan jangkitan kuman Gram negatif di dalam darah yang 
resistan terhadap Carbapenem, berdasarkan analisis ‘Multiple Logistic Regression’ 
 xiii 
 
adalah tempoh rawatan di ICU (OR 2.09, 95 % CI 1.01–33.18, p=0.019), adanya 
penyakit Diabetes Mellitus (OR 3.5, 95 % CI 1.61–13.24, p =0.016), pesakit yang 
mempunyai tiub trakeostomi (OR 5.17, 95% CI 1.94 – 18.92, p=0.010) dan tiub aliran 
cecair paru-paru (chest drain) (OR 5.79, 95% CI, 4.27 – 24.40, p = 0.016), sejarah 
penggunaan Carbapenem (OR 5.90, 95% CI, 4.63 – 7.40, p=  0.002) dan pesakit yang 
dijangkiti oleh  kuman Acinetobacter baumannii (OR 6.18, 95% CI, 2.56 – 8.68, p = 
0.010) dan juga Pseudomonas aeruginosa (OR 4.29, 95% CI, 0.22 – 8.48, p = 0.034).  
  Secara amnya, jumlah kematian  di dalam kumpulan pertama (control) adalah lebih 
tinggi berbanding dengan kumpulan kedua (case). Walaubagaimana pun, bukti ini 
secara statistiknya kurang meyakinkan (p = 0.679). 
Kematian langsung yang berpunca daripada jangkitan kuman Gram negatif resistan 
Carbapenem adalah lebih tinggi (24 pesakit) berbanding kumpulan yang sensitive 
Carbapenem (17 pesakit) (p=0.011).   
 
Kesimpulan : Penyelidikan ini menjelaskan kepentingan pencegahan jangkitan kuman 
Gram negatif yang resistan dan kebijaksanaan dalam penggunaan antibiotic untuk 
mengurangkan kematian langsung. 
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ABSTRACT 
 
RISK FACTORS AND OUTCOMES OF CARBAPENEM-RESISTANT GRAM-
NEGATIVE BLOOD STREAM INFECTION IN INTENSIVE CARE UNIT, 
HUSM 
 
Objectives:  Carbapenem-resistant (CR) Gram-negative pathogens have increased 
substantially and is worrisome. This study was performed to identify the risk factors for 
development as well as outcomes of CR Gram-negative bacteremia (GNB)  among 
patients in Intensive Care Unit (ICU), Hospital Universiti Sains Malaysia (HUSM). 
  
Methods:  Retrospective, case-control study; risk factors for development of CR-
GNB were investigated using two groups of patients: the ﬁrst group (control) consisted 
of patients who acquired carbapenem susceptible (CS) GNB and the second group 
(case) included patients with CRGNB. The case groups were compared to the control 
group deﬁned as patients hospitalized in the ICU during the same period, with similar 
inclusion and exclusion criterias. 96 cases of Gram-negative bacilli BSI from ICU were 
randomly selected and their medical record were traced from Record Office and 
reviewed. Their demographic profiles, underlying diseases, potential risk factors, 
antibiotic usage,  microbiology results and outcome were reviewed. 
 
 Results:  Total 96 patients were included for the study, 48 patients with CR- were 
compared to 48 patients with CS-GNB. Increased length of ICU stay (OR 2.09, 95 % CI 
1.01–33.18, p=0.019), DM (OR 3.5, 95 % CI 1.61–13.24, p =0.016), presence of 
tracheostomy and chest drain (OR 5.17, 95% CI 1.94 – 18.92, p=0.010) and (OR 5.79, 
 xv 
 
95% CI, 4.27 – 24.40, p = 0.016) respectively, prior exposure to carbapenems (OR 5.90, 
95% CI, 4.63 – 7.40, p=  0.002) and those who have infected by Acinetobacter 
baumannii (OR 6.18, 95% CI, 2.56 – 8.68, p = 0.010) and Pseudomonas aeruginosa (OR 
4.29, 95% CI, 0.22 – 8.48, p = 0.034)  were independent risk factors associated with 
CR-GNB.  
Crude mortality in CS-GNB was greater compared to CR group, however, statistically 
not significant (p = 0.679). Meanwhile, the attributable mortality in CR-GNB was noted 
higher than CS-GNB (24 patients in CR compared to 17 patients in CS-GNB), with 
p=0.011.   
 
 Conclusions:  This study indicates the importance of preventing CR-GNB blood 
stream infections and the appropriate use of antimicrobial agents to reduce attributable 
mortality. 
ABSTRACT 
 
RISK FACTORS AND OUTCOMES OF CARBAPENEM-RESISTANT GRAM-
NEGATIVE BLOOD STREAM INFECTION IN INTENSIVE CARE UNIT, 
HUSM 
 
Dr Rozila Bt Aziz 
MMed Anaesthesiology 
 
Department of Anaesthesiology 
School of Medical Sciences, Universiti Sains Malaysia 
Health Campus, 16150 Kelantan, Malaysia 
 
Objectives:  Carbapenem-resistant (CR) Gram-negative pathogens have increased 
substantially and is worrisome. This study was performed to identify the risk factors for 
development as well as outcomes of CR Gram-negative bacteremia (GNB)  among 
patients in Intensive Care Unit (ICU), Hospital Universiti Sains Malaysia (HUSM). 
  
Methods:  Retrospective, case-control study; risk factors for development of CR-
GNB were investigated using two groups of patients: the ﬁrst group (control) consisted 
of patients who acquired carbapenem susceptible (CS) GNB and the second group 
(case) included patients with CRGNB. The case groups were compared to the control 
group deﬁned as patients hospitalized in the ICU during the same period, with similar 
 ii 
 
inclusion and exclusion criterias. 96 cases of Gram-negative bacilli BSI from ICU were 
randomly selected and their medical record were traced from Record Office and 
reviewed. Their demographic profiles, underlying diseases, potential risk factors, 
antibiotic usage,  microbiology results and outcome were reviewed. 
 
 Results:  Total 96 patients were included for the study, 48 patients with CR- were 
compared to 48 patients with CS-GNB. Increased length of ICU stay (OR 2.09, 95 % CI 
1.01–33.18, p=0.019), DM (OR 3.5, 95 % CI 1.61–13.24, p =0.016), presence of 
tracheostomy and chest drain (OR 5.17, 95% CI 1.94 – 18.92, p=0.010) and (OR 5.79, 
95% CI, 4.27 – 24.40, p = 0.016) respectively, prior exposure to carbapenems (OR 5.90, 
95% CI, 4.63 – 7.40, p=  0.002) and those who have infected by Acinetobacter 
baumannii (OR 6.18, 95% CI, 2.56 – 8.68, p = 0.010) and Pseudomonas aeruginosa (OR 
4.29, 95% CI, 0.22 – 8.48, p = 0.034)  were independent risk factors associated with 
CR-GNB.  
Crude mortality in CS-GNB was greater compared to CR group, however, statistically 
not significant (p = 0.679). Meanwhile, the attributable mortality in CR-GNB was noted 
higher than CS-GNB (24 patients in CR compared to 17 patients in CS-GNB), with 
p=0.011.   
 
 Conclusions:  This study indicates the importance of preventing CR-GNB blood 
stream infections and the appropriate use of antimicrobial agents to reduce attributable 
mortality. 
 
 iii 
 
Professor Dr. Shamsul Kamalrujan Hassan : Supervisor 
Dr Rhendra Hardy Mohamad Zaini  : Co-Supervisor 
Associate Professor Madya Dr Zakuan Zaini Deris : Co-Supervisor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
 
ABSTRAK 
 
FAKTOR RISIKO DAN HASIL AKIBAT JANGKITAN KUMAN GRAM 
NEGATIF DALAM DARAH YANG RESISTAN CARBAPENEM DI UNIT 
RAWATAN RAPI (ICU), HUSM 
 
Dr Rozila Bt Aziz 
MMed Anaesthesiologi 
 
Jabatan Anaesthesiologi,  
Pusat Pengajian Sains Perubatan 
Kampus Kesihatan, 16150 Kelantan, Malaysia 
 
Objektif : Jangkitan kuman gram negatif semakin berleluasa dan amat 
membimbangkan. Penyelidikan ini dijalankan bertujuan untuk mengenalpasti faktor 
risiko dan juga hasil akibat jangkitan kuman Gram negatif di dalam darah pesakit-
pesakit ICU, Hospital Universiti Sains Malaysia (HUSM).  
 
Metodologi : Retrospektif, dijalankan secara perbandingan “case-control”. Faktor risiko 
terhadap jangkitan kuman Gram negatif dikenalpasti dengan membandingkan dua 
kumpulan pesakit : kumpulan pertama (control) terdiri daripada kes yang mempunyai 
jangkitan kuman Gram negatif yang sensitive kepada Carbapenem dan kumpulan kedua 
(case) pula terdiri daripada kes yang resistan. Kedua-dua kumpulan ini adalah kes yang 
 v 
 
dirawat di ICU dalam tempoh yang sama dan memenuhi syarat-syarat kriteria yang 
diperlukan. 96 sample tersebut telah dipilih secara rawak dan rekod perubatan kes-kes 
ini dilihat kembali. Data demografik, sejarah penyakit dahulu, penggunaan antibiotik, 
keputusan mikrobiologi dan hasilnya dicatat. 
 
Keputusan : Daripada 96 sampel yang dikaji, sebanyak 48 kes yang resistan telah 
dibandingkan dengan 48 kes yang sensitif terhadap Carbapenem. Antara faktor risiko 
yang dikenalpasti menyebabkan jangkitan kuman Gram negatif di dalam darah yang 
resistan terhadap Carbapenem, berdasarkan analisis ‘Multiple Logistic Regression’ 
adalah tempoh rawatan di ICU (OR 2.09, 95 % CI 1.01–33.18, p=0.019), adanya 
penyakit Diabetes Mellitus (OR 3.5, 95 % CI 1.61–13.24, p =0.016), pesakit yang 
mempunyai tiub trakeostomi (OR 5.17, 95% CI 1.94 – 18.92, p=0.010) dan tiub aliran 
cecair paru-paru (chest drain) (OR 5.79, 95% CI, 4.27 – 24.40, p = 0.016), sejarah 
penggunaan Carbapenem (OR 5.90, 95% CI, 4.63 – 7.40, p=  0.002) dan pesakit yang 
dijangkiti oleh  kuman Acinetobacter baumannii (OR 6.18, 95% CI, 2.56 – 8.68, p = 
0.010) dan juga Pseudomonas aeruginosa (OR 4.29, 95% CI, 0.22 – 8.48, p = 0.034).  
  Secara amnya, jumlah kematian  di dalam kumpulan pertama (control) adalah lebih 
tinggi berbanding dengan kumpulan kedua (case). Walaubagaimana pun, bukti ini 
secara statistiknya kurang meyakinkan (p = 0.679). 
Kematian langsung yang berpunca daripada jangkitan kuman Gram negatif resistan 
Carbapenem adalah lebih tinggi (24 pesakit) berbanding kumpulan yang sensitive 
Carbapenem (17 pesakit) (p=0.011).   
 
 vi 
 
Kesimpulan : Penyelidikan ini menjelaskan kepentingan pencegahan jangkitan kuman 
Gram negatif yang resistan dan kebijaksanaan dalam penggunaan antibiotic untuk 
mengurangkan kematian langsung. 
 
Profesor Dr. Shamsul Kamalrujan Hassan : Supervisor 
Dr Rhendra Hardy Mohamad Zaini  : Co-Supervisor 
Profesor Madya Dr Zakuan Zaini Deris : Co-Supervisor 
 
 
 
 
1 
 
CHAPTER 1 
1.0 INTRODUCTION 
 
The prevalence of Gram-negative bacterial pathogens which are resistant to 
multiple antimicrobial agents is rising in hospitals, and exclusively in intensive care unit 
(ICU) settings (Rahal, 2009). Livermore and Woodford (2006) stated that the growing 
prevalence of infections caused by multidrug-resistant Pseudomonas aeruginosa, 
Acinetobacter baumannii, and Klebsiella pneumoniae has directed to a major medical 
problem globally. 
 
Carbapenems, such as meropenem and imipenem, are currently considered to be 
the ideal means for the management of severe bacterial infections produced by 
multidrug-resistant Gram-negative pathogens, mostly Enterobacteriaceae, 
Pseudomonas aeruginosa, and nonfermenters, i.e., Acinetobacter baumannii (Paterson, 
2006).  
 
 However, the emergence of carbapenem resistance among Gram-negative 
pathogens has been more and more reported worldwide and is a matter of great concern, 
ever since it complicates both empirical and guided treatment. Moreover, carbapenem 
resistance is also associated with additional mechanisms of resistance to other antibiotic 
classes (Grundmann et al., 2010). This was proven by a study done by Routsi et al. 
(2013) stated an increased rate of carbapenem resistant (CR) A. baumannii isolates was 
detected.   
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This study is conducted to identify characteristics of patients who developed 
Carbapenem - Resistant Gram - negative bacteremia (GNB) in the intensive care unit 
(ICU), Hospital Universiti Sains Malaysia (HUSM), risk factors for acquisition of it, 
and outcomes of getting Carbapenem - Resistant Gram – negative bacilli infections. 
Such knowledge should be useful to identify patients at risk, so that they receive in time 
a targeted antimicrobial therapy. 
 
There have been many studies regarding Carbapenem - resistant (CR) and 
multidrug - resistant (MDR) gram negative bacilli (GNB) worldwide. The study by 
Routsi et al., (2013), University of Athens, Greece stated that Carbapenem- susceptible 
(CS) GNB were most common due to A. baumanni (57.2%) and K. pneumoniae (25%). 
Carbapenem-resistant GNB were most common due to A. baumannii (37.6%) and P. 
aeroginosa (36.5%). Respiratory tract infection was the most common source in both 
Carbapenem – susceptible (CS) and Carbapenem-resistant (CR) gram – negative bacilli 
(GNB), observed in 45% and in 47% patients respectively, followed by other sources in 
19% and 13% patients respectively. However, the result of the studies might not 
represent our local situation since there are very large differences among hospitals, 
setting, regions or countries. 
 
Data issued in 2004 from the United State National Nasocomial Infection 
Surveillance System (NNIS) report resistant rates among P.aeruginosa isolates to 
imipenem and quinolones at 21.1% and 29.5% respectively; in intensive care unit (ICU) 
isolates, the respective rates of resistance were even higher (up to 51.6% for 
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ciprofloxacin, 31.4% for piperacillin/tazobactam, 38% for imipenem and 23.6% for 
ceftazidime). 
 
Relevant figures for ICU isolates of Pseudomonas aeruginosa adopted from 
Europe are even worse, as from 1990 through to 1999 resistance to aminoglycosides 
reached 37% – 70%, to ceftazidime 57%, to piperacillin/tazobactam 53%, to 
ciprofloxacin 56% and to imipenem 52% (Rossolini et al., 2007).  
 
Multidrug - resistant (MDR) A.baumannii isolates are becoming one of the 
supreme serious therapeutic problems worldwide. Data from the NNIS indicate that 
from 1986 to 2003, among Acinetobacter organisms causing pneumonia in ICUs, 
resistance to imipenem had increased from 0% to 42% and to ceftazidime from 18% to 
68%. The significant rise in the incidence of A. baumannii among nosocomial 
pathogens has explained this microorganism as an unarguable indicator of poor clinical 
outcomes. (McDonald, 2006) and (Abbo et al., 2007). 
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 1.1 RATIONALE OF STUDY 
It is hoped that the results will help clinician to gain : 
 
 Better knowledge and understanding regarding  the risk factors of developing 
Carbapenem – resistant gram - negative bacilli blood - stream infection and 
outcomes of patients in our  local situation since there are very large variations 
among regions, countries, hospitals or settings. 
 
 Knowledge of the patient characteristics associated with Carbapenem - resistant 
gram - negative bacilli blood - stream infection  will help in recognizing them 
and avoid further complications. 
 
 Increase awareness of treatment failure and early consideration of salvage 
antibiotics such as polymyxin B and colistin may potentially lead to improve 
outcomes. 
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CHAPTER 2 
2.0 LITERATURE REVIEW 
 
2.1 INFECTION 
Infection is defined as invasions and multiplication of microorganisms (bacteria, 
virus, fungi and/or parasites) in body tissues, causing local cellular injury due to 
competitive metabolism, toxins, intracellular replication, or antigen-antibody response 
(Dorland, 2007). 
 
It is caused by microbes as below : 
 
 Bacteria like Gram-positive bacteria (Staphylococci, Streptococci) and Gram-
negative bacteria(E-coli, Pseudomonas aeruginosa and Klebsiella pneumoniae) 
 Viruses, like virus influenzae or HIV 
 Fungi, like one-cell yeasts Candida species or Aspergillus 
 One-cell parasites (protozoa) like Giardia or Entameba histolytica (Modric, 
2009) 
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The route of infection can be via : 
 
 airborne infection : 
o   one that is contracted by inhalation of microorganisms or spores 
suspended in air on water droplets or dust particles. 
 
 droplet infection : 
o  infection due to inhalation of respiratory pathogens suspended on liquid 
particles exhaled by someone already infected (droplet nuclei) . 
 
 endogenous infection : 
o  that due to reactivation of organisms present in a dormant focus, as 
occurs in tuberculosis, etc. 
 
 tunnel infection : 
o  subcutaneous infection of an artificial passage into the body that has 
been kept patent. 
 
 opportunistic infection : 
o  infection by an organism that does not normally cause disease but 
becomes pathogenic under certain environments (e.g., diminished 
immune responses) (Dorland, 2007) 
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Figure 2.1 :  Chain of infection, adopted from  Dorland's Medical Dictionary for 
Health Consumers. (2007) 
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Figure 2.2 : 
Stages of infection, each period varies with different pathogens and different 
diseases, adopted from  Dorland's Medical Dictionary for Health Consumers. (2007) 
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2.2 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME  (SIRS) 
Systemic inflammatory response to a variety of severe clinical insults. The response 
is manifested  by two or more of the following signs (Bone et al., 2009): 
 A temperature >38 or <36oC 
 Heart rate >90 beats per minute 
 Respiratory rate >20 breaths per minute or a PaCO2 <32 mmHg 
 White blood cell count >12,000/mm3 or<4000/mm3, or the presence of >10% 
immature forms. 
 
2.3 SEPSIS 
The ACCP/ SCCM Consensus Conference Definitions (1992) defined sepsis is 
the systemic inflammatory response to infection, i.e. SIRS due to a presumed or 
identified site of infection. In association with infection, manifestations of sepsis are the 
same as those previously defined for SIRS. It is a clinical term used to define a patient 
who has symptomatic bacteremia, with or without organ dysfunction. It should be 
determined whether they are a direct systemic response to the presence of an infectious 
process and represent an acute modification from baseline in the absence of other 
known causes for such abnormalities (Bone et al., 2009). 
 
Dorland (2007) defined sepsis as the presence of pathogenic microorganisms or 
their toxins in the blood or other tissues.  
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Or in other words, infection together with the systemic manifestation of infection. A 
suspected or documented infection in the presence of the following is defined as sepsis : 
 
 Temperature >38 or <36oC 
 Heart rate >90 beats per minute 
 Tachypnoea : respiratory rate >20 breaths per minute or a PaCO2 <32 mmHg 
 White blood cell count >12,000/mm3 or<4000/mm3, or the presence of >10% 
immature forms. 
 Altered mental status. 
 Hyperglycemia (plasma glucose 140mg/dL or 7.7 mmol/L) in the absence of 
diabetes  (Radford, 2013). 
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2.4 SEVERE SEPSIS 
 Severe sepsis is defined as sepsis associated with organ dysfunction, 
hypoperfusion or hypotension. Hypoperfusion and perfusion abnormalities may include 
but are not limited to lactic acidosis, oliguria or an acute alteration in mental status 
(Radford, 2013). 
 
 Sepsis-induced hypotension is defined as a systolic blood pressure <90 
mmHg or mean arterial pressure <70 mmHg or decrease in SBP > 40mmHg below the 
normal for age in the absence of other causes of hypotension  (Radford, 2013). 
 
2.5 SEPTIC SHOCK 
 Septic shock is defined as sepsis associated with hypotension (systolic blood 
pressure < 90 mmHg, mean arterial pressure < 60 mmHg, or systemic blood pressure < 
40 mmHg from baseline) despite satisfactory fluid resuscitation.  
 
 Septic shock is usually characterized by inadequate tissue perfusion and 
extensive cellular dysfunction. In contrast to other forms of shock (hypovolaemic, 
cardiogenic, or anaphylactic), cellular dysfuction in septic shock is not necessarily 
related to the hypoperfusion. Instead, there may be a metabolic block at the cellular 
level that contributes to impaired cellular oxidation (Morgan, 2006). 
 
12 
 
  In simple sentences, septic shock is severe sepsis with hypotension after 
adequate fluid resuscitation (Bone et al., 2009). 
 
2.6 COMMUNITY-ACQUIRED INFECTION 
 Community-acquired infection is defined as infection derived from outside of 
a health care setting or an infection present on admission. It is often distinguished from 
hospital-acquired or nosocomial infection by the types of microorganisms that affect 
patients who are recovering from a disease or injury (Mosby, 2009). Community-
acquired respiratory infections commonly involve strains of Haemophilus influenza or 
Streptococcus pneumonia and are usually more antibiotic sensitive. 
 
2.7 HOSPITAL-ACQUIRED INFECTION 
 Hospital - acquired or nosocomial infections is defined as those occurring 
within 48 hours of hospital admission, 3 days of discharge or 30 days of an operation.  
 
 They affect 1 in 10 patients admitted to hospital. Approximately, a patient 
with hospital acquired infection spent 2.5-times longer in hospital, with additional costs 
more than an uninfected patient (Inweregbu et al., 2005). 
  
  Intensive care units (ICU) have the highest incidence of hospital-acquired 
infections in the hospital setting. The European Prevalence of Infection in Intensive 
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Care Study (EPIC), involving over 4500 patients, demonstrated that the nosocomial 
infection prevalence rate in ICU was quite high, 20.6% (Inweregbu et al., 2005). 
. 
  ICU patients are particularly at risk from nosocomial infections as a result of 
mechanical ventilation, use of invasive procedures and their immunocompromised 
status (Inweregbu et al., 2005). 
 
 Gram-positive bacteria are the commonest source of nosocomial infections 
with Staphylococcus aureus being the predominant pathogen. However, gram-negative 
nosocomial infection was noted to be significantly increased in trend since 1986 
(Weinstein et al., 2005). The study showed that gram-negative bacilli continue to be 
associated with hospital-acquired infections in intensive care units (ICUs).  
 
 Weinstein et al. (2005) also stated that since 1970s, gram-negative bacilli 
constituted the majority of bacterial pathogens associated with the four major types of 
hospital-acquired infections : 
1. Nosocomial pneumonia 
 Gram-negative aerobes continued the most commonly described 
bacterial pathogens associated with pneumonia in 2003 (65.9%), with the 
percentage of Acinetobacter species was significantly higher. 
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2. Urinary tract infection (UTI) 
 The most commonly reported gram-negative pathogens were E.coli, 
followed by Pseudomonas aeruginosa. However, the percentage of 
Klebsiella pneumonia and Acinetobacter isolates had increased 
significantly in the year of 2003. 
 
3. Surgical site infection (SSI) 
 Acinetobacter isolates were more frequently reported. 
 
4. Primary blood-stream infection (BSI) 
 Centers for Disease Control and Prevention (CDC) defined specifically, 
that primary bloodstream infection includes  a laboratory-confirmed 
bloodstream infection and clinical sepsis. It must meet one of the 
following criteria : 
 
1. Recognized pathogen isolated from blood culture and  pathogen is 
not related to infection at another site. OR  
 
2. One of the following: fever  > 38 oC, chills, or hypotension AND any 
of the following: 
  
i. Common skin contaminant isolated from two blood cultures 
drawn on separate occasions AND the organism is not related to 
infection at another site **.  
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ii. Common skin contaminant isolated from blood culture from 
patient with intravascular access device, plus the physician 
introduces appropriate antimicrobial therapy 
 
 
iii. Positive antigen test on blood and organism is not related to 
infection at another site (Digiovine et al., 1999). 
 
3. Patient < 12 months of age has one of the following : fever > 38 oC, 
hypothermia (<37
o 
C), bradycardia or apnea, and any of the following 
: 
i. Common skin contaminant isolated from two blood 
cultures drawn on separate occasions and organism is 
not related to infection at another site **. 
ii. Common skin contaminant isolated from blood 
culture from patient with intravascular access device, 
and physician institutes appropriate antimicrobial 
therapy. 
 
iii. Positive antigen test on blood and pathogen is not 
related to infection at another site (Garner et al., 
1988). 
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** when an organism isolated from blood culture is compatible with an associated 
nosocomial infection at another site, the blood - stream infection is categorized as a 
secondary blood stream - infection. Exceptions to this are intravascular device – 
associated blood stream infections, all of which are categorized as primary if localized 
signs of infection are present at the access site (Garner et al., 1988) 
  
 There has been a growth in the degree of antibiotic resistant bacteria 
associated with nosocomial infections in ICU. Bacteria develop resistance when they 
acquire new genetic material. Poor antibiotic prescribing selects for resistant bacteria.  
 
 This highlights the need for the use of appropriate and adequate antibiotics 
because inadequate antibiotic therapy is associated with poor outcome and emergence 
of bacterial resistance. 
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Factors that predispose to nosocomial infections: Adopted from The European 
Prevalence of Infection in Intensive Care Study (EPIC); adopted from (Inweregbu 
et al., 2005) : 
1) Related to underlying health status  
 Advanced age  
 Malnutrition  
 Alcoholism  
 Heavy smoking  
 Chronic lung disease 
 Diabetes 
  
2) Related to acute disease process 
 Surgery 
 Trauma  
 Burns  
 
3) Related to invasive procedures  
 Endotracheal or nasal intubation 
 Central venous catheterisation  
 Extracorporeal renal support  
 Surgical drains  
 Nasogastric tube  
 Tracheostomy  
 Urinary catheter 
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4) Related to treatment  
 Blood transfusion  
 Recent antimicrobial therapy  
 Immunosuppressive treatments  
 Stress-ulcer prophylaxis  
 Recumbent position  
 Parenteral nutrition  
 Length of stay 
 
2.7.1 BLOOD-STREAM INFECTION 
 Bloodstream infection (BSI) is the most frequent and common infection in 
critically ill patients. As blood - stream infections  among patients in intensive care units 
(ICU’s) are usually secondary to intravascular catheters, they can be triggered by both 
Gram-positive and Gram-negative microorganisms as well as fungi. Infection with 
multidrug - resistant (MDR) organisms is becoming more frequent and common, 
making the choice of empirical antimicrobial therapy more challenging.  
 
 Karchmer (2000) stated that, clinical bloodstream infections (BSIs), which 
characterize the failure of the immune system to surround infection at a focal site and 
resulting disseminated disease, are a major reason of morbidity and mortality.  
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The rate of these infections, their epidemiology, and the invading organisms 
have changed in parallel with the expansion of medical care, predominantly with the 
development of an ever more ill and immunocompromised population of hospitalized 
patients who are often seriously dependent on medical support and indwelling devices.  
 
Currently more than 50% of blood - stream infections are hospital acquired and 
it is estimated that hospitalized patients in the United States have 250,000 episodes of 
nosocomial blood - stream infections yearly, and when these infections occur in patients 
in intensive care units, they are associated with an attributable mortality rate of 35%, 
24% additional hospital days, and extra hospital costs of $40,000 per survivor 
(Karchmer, 2000). 
 
2.7.1.1 GRAM-POSITIVE BACTEREMIA : 
 The incidence of Gram-positive bloodstream infections also has been 
increasing progressively. Currently, the 3 most common causes of nosocomial blood-
stream infections  in the United States are coagulase-negative staphylococci, 
Staphylococcus aureus, and Enterococci spp. (Karchmer, 2000). 
 
 The virulence of coagulase-negative staphylococci is based mostly on their 
capability to produce biofilms, and thus cause infections of intravascular devices and 
foreign bodies, which must be removed to resolve the infection. Staphylococcus aureus 
is the leading cause of endocarditis, and it is important to recognize patients at risk of 
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the complications of Staphylococcus aureus bloodstream infections. Enterococci spp. 
are the third leading cause of Gram-positive bacteraemia in our institution. Management 
of this disease is difficult because of its intrinsic resistance to antibiotics, mainly in 
Enterococcus faecium infections (Karchmer, 2000).  
  
 The recently defined synergism of ampicillin plus ceftriaxone is a good 
therapeutic option for Enterococcus faecalis bacteraemia and endocarditis produced by 
high-level aminoglycoside-resistant strains (Karchmer, 2000).  
 
 Nosocomial bacteremia caused by viridans streptococci and S. aureus occurs 
prior during hospitalization than does bacteremia caused by gram-negative bacilli, 
Candida, and enterococci. The average time to commencement of bacteremia caused by 
streptococci and S. aureus is ∼2 weeks after the start of hospitalization. Gram-negative 
bacilli, Candida, and enterococci are encountered in blood cultures on average a week 
or so longer after the start of hospitalization. The mean period to onset of bacteremia 
caused by coagulase-negative staphylococci is ∼19 days after the start of hospitalization 
(Rello, 1999).  
 
Organisms producing nosocomial blood - stream infections differ depending on 
the site of patients within the institution. Coagulase-negative staphylococci are more 
likely to be isolated from cultures of blood specimens from patients in intensive care 
settings, while viridans streptococci and Staphylococcus aureus are more frequently 
isolated from ward patients. Enterococci are isolated with similar frequency from 
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patients in both settings. Blood - stream infections caused by viridans streptococci are 
associated with neutropenia and are commonly detected in patients on the hematology 
and oncology services. Crude mortality rates among patients with blood - stream 
infections caused by these gram-positive cocci range from 17% to 32%, the lowest 
mortality rates are associated with coagulase-negative staphylococci, and the highest 
mortality rates have been presented among patients with enterococcal bacteremia (Pittet 
et al., 1994). 
 
2.7.1.2 GRAM-NEGATIVE BACTEREMIA : 
 Gram-negative bacteremia was defined as the isolation of gram-negative 
bacilli in a blood culture specimen. Orsini et al. (2012) stated that the most common 
Gram-negative bacteria isolated from blood culture were Klebsiella spp with 80% of 
Klebsiella pneumonia, followed by Acinetobacter baumannii and E. coli .  Kang et al. 
(2011)  stated gram-negative bacilli such as Enterobactericeae and Pseudomonas 
aeruginosa are the prominent causes of nosocomial blood stream infections. Among the 
gram-negative bacilli, antibiotic-resistant strains have been emerged dramatically and 
are being increasingly concerned. 
 
 The most common ESBL-producers were Klebsiella pneumoniae  and 
Acinetobacter baumannii, where as Carbapenem-resistant phenotype were Klebsiella 
pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. The most 
common risk factors for MDR infections were diabetes mellitus and malignancy. 
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 The epidemiology of microorganisms producing blood stream infections 
radically changed over years, with a simultaneous increase in antimicrobial resistance. 
A nationwide surveillance study directed in 49 hospitals in USA showed a large 
prevalence of Gram-positive bacteria causing blood - stream infection compared with 
Gram-negative organisms. However, a trend towards an increasing incidence of Gram-
negative organisms causing blood - stream infections has been observed more in recent 
times (Orsini et al., 2012). 
 
2.7.1.3 FUNGI : 
 Candida albicans blood - stream infections are the most common invasive 
fungal infections among hospitalized patients. In the USA, it is currently the fourth 
prominent cause of nosocomial blood - stream infections among hospitalized patients 
and third among ICU patients. The incidence and epidemiology of invasive candidiasis 
in the ICU’s has undergone significant change in the past decades. Significant regional 
and geographic variations exist in the incidence of the different Candida species. Kett et 
al. (2011) reported Candida albicans as the most common Candida species isolated 
among patients in ICU’s [(Wisplinghoff et al., 2004), (Kett et al., 2011). 
  
 In some series, non-albicans species account for almost half of all Candida 
blood - stream infections. Candida glabrata is generally the second most commonly 
isolated pathogen in North America [(Wisplinghoff et al., 2004, (Horn et al., 2009).  
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 Retrospective cohort studies have been commenced to approximate mortality 
attributable to candidemia and report rates ranging from 10% to 49%, with increase in 
the hospital costs. The gold standard diagnostic test for invasive candidiasis has been 
isolation of the organism by blood culture. Detection of candidemia by blood culture 
often takes more than 24 hours. For certain species, such as Candida glabrata, the time 
can be even longer, leading to a significant delay in appropriate therapy and higher 
mortality (Posteraro et al., 2011).  
 
2.8 MULTIDRUG RESISTANT GRAM-NEGATIVE BACILLI 
 Development of resistance to multiple antimicrobial agents in pathogenic 
bacteria has become a significant public health risk as there are fewer, or even 
sometimes no effective antimicrobial agents obtainable for infections produced by these 
bacteria. Gram-positive and Gram-negative bacteria are both affected by the 
development and rise of antimicrobial resistance. 
 
 Multidrug resistant in gram-negative organisms was defined as resistance to 
at least one antimicrobial in three or more antimicrobials classes: aminoglycosides, third 
generation cephalosporins, fluoroquinolones, and carbapenems, including organisms 
with Extended-Spectrum β-Lactamases (ESBL’s), and Carbapenem-Resistant  
Enterobacteriaceae (CRE). Among the Gram-positive organisms, multidrug resistant 
was defined as methicillin resistance in Staphylococcus aureus and vancomycin 
resistance in Enterococcus species (Orsini et al., 2012). 
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2.8.1 DRUG – RESISTANCE DEFINITIONS 
 According to Magiorakos et al. (2012), the resistance characteristic of 
microorganisms is categorized into: 
 
 multidrug-resistant (MDR) is deﬁned as non-susceptibility to at least one agent 
in three or more antimicrobial categories. 
  
 extensively drug-resistant (XDR) is deﬁned as non-susceptibility to at least one 
agent in all but two or fewer antimicrobial categories (i.e. bacterial isolates 
remain susceptible to only one or two categories). 
 
  
 pandrug-resistant (PDR) is deﬁned as non-susceptibility to all agents in all 
antimicrobial categories (i.e. no agents tested as susceptible for that organism).  
 
Therefore, a bacterial isolate that is categorized as entensively drug – resistant (XDR) 
will also be categorized as multi drug - resistant (MDR). Equally, a bacterial isolate 
would have to be extensively drug - resistant (XDR) in order for it to be further deﬁned 
as pandrug - resistant (PDR). 
 
 
 
